Molecular Formula | C21H23NO3 |
Molar Mass | 337.41 |
Density | 1.178±0.06 g/cm3(Predicted) |
Melting Point | 172-174℃ |
Boling Point | 563.1±50.0 °C(Predicted) |
Solubility | DMSO: ≥20 mg/mL |
Appearance | White to white-like powder |
Color | White to Off-White |
pKa | 3.49±0.36(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
In vitro study | N-(p-amylcinnamoyl) Anthranilic Acid (ACA; 20 μM) completely blocks ADPR-induced whole-cell currents and H 2 O 2 -induced Ca 2+ signals (IC 50 =1.7 μM) in HEK293cells transfected with human TRPM2. N-(p-amylcinnamoyl) Anthranilic Acid (ACA; 20 μM) also blocks currents through human TRPM8 and TRPC6 expressed in HEK293 cells. N-(p-amylcinnamoyl) Anthranilic Acid (ACA) modulates the activity of different TRP channels independent of PLA2 2 inhibition. |
Hazard Class | 9 |
biological activity | N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is an inhibitor of broad-spectrum phospholipase A2 (PLA2) and a blocker of TRP channel. N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is also an effective reversible inhibitor of calcium-activated chloride channels (calcium-activated chloride channels), which has the potential to be used in arrhythmia related research. |
target | PLA 2 . TRP channel. Calcium-activated chloride channels. |